Cardlytics (CDLX) Tops Q1 EPS by 60c

Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.25), $0.60 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $64.3 million versus the consensus estimate of $64.07 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• Schwab's May activity shows margin loans nearly double